Do you want to read an article? Please log in or register.
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
Clinical Effectiveness of the Anti-Fibrotic Medications for Idiopathic Pulmonary Fibrosis
Am J Respir Crit Care Med.
Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH
doi: 10.1164/rccm.
Pulmonary Hypertension
Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells
PLoS One.
Lambers C, Kornauth C, Oberndorfer F, Boehm PM, Tamm M, Klepetko W, Roth M
doi: 10.1371/journal.pone.
RECOMMENDED
Pulmonary Fibrosis
Adoption of the Anti-Fibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Am Thorac Soc
Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH
doi: 10.1513/AnnalsATS.202007-901OC
COMMENTED
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
Lancet Respir Med.
Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME, Moran S, Castro de Moura M, Davalos V, Piñeyro D, Sanchez-Cespedes M, Girard N, Brevet M, Giroux-Leprieur E, Dumenil C, Pradotto M, Bironzo P, Capelletto E, Novello S, Cortot A, Copin MC, Karachaliou N, Gonzalez-Cao M, Peralta S, Montuenga LM, Gil-Bazo I, Baraibar I, Lozano MD, Varela M, Ruffinelli JC, Palmero R, Nadal E, Moran T, Perez L, Ramos I, Xiao Q, Fernandez AF, Fraga MF, Gut M, Gut I, Teixidó C, Vilariño N, Prat A, Reguart N, Benito A, Garrido P, Barragan I, Emile JF, Rosell R, Brambilla E, Esteller M
doi: 10.1016/S2213-
SPECIAL REPORT
Interstitial Lung Disease
OFEV® extended indication offers new hope for patients with SSc-ILD
RECOMMENDED
Pulmonary Fibrosis
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Cell Mol Biol.
Ruwanpura SM, Thomas BJ, Bardin PG
doi: 10.1165/rcmb.2019-0328TR.
RECOMMENDED
Pulmonary Fibrosis
Fibroblasts positive for meflin have anti-fibrotic property in pulmonary fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Nakahara Y, Hashimoto N, Sakamoto K, Enomoto A, Adams TS, Yokoi T, Omote N, Poli S, Ando A, Wakahara K, Suzuki A, Inoue M, Hara A, Mizutani Y, Imaizumi K, Kawabe T, Rosas IO, Takahashi M, Kaminski N, Hasegawa Y
doi: 10.1183/13993003.03397-2020
COPD
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Respir Res.
Cazzola M, Calzetta L, Facciolo F, Rogliani P, Matera MG
doi: 10.1186/s12931-016-0500-y.
Pulmonary Fibrosis
Autophagy and the Unfolded Protein Response Promote Pro-fibrotic Effects of TGFβ1 in Human Lung Fibroblasts
Am J Physiol Lung Cell Mol Physiol.
Ghavami S, Yeganeh B, Zeki AA, Shojaei S, Kenyon NJ, Ott S, Samali A, Patterson J, Alizadeh J, Moghadam AR, Dixon IMC, Unruh H, Knight DA, Post M, Klonisch T, Halayko AJ
doi: 10.1152/ajplung.00372.2017.